King Rachel K. bought NVAX
June 18, 2026 · Form 4 insider transaction
King Rachel K. bought 21,270 shares of Novavax, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
21,270
Price
$0.00
Total value
N/A
InsiderKing Rachel K.
RoleDirector
CompanyNovavax, Inc. (NVAX)
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJune 18, 2026
Filing dateJune 23, 2026
Shares owned after21,270
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
One hundred percent (100%) of the shares subject to this option grant under the Amended and Restated 2015 Stock Incentive Plan, as amended, will vest on the first anniversary of the June 18, 2026 grant date subject to continued service on the Company's Board of Directors through the vesting date.